Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination.

Kameyama N, Ide A, Maeda H

Open source

DOI
10.1007/s40199-026-00661-7
Published
2026 Sep 18
Container
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40199-026-00661-7,
  title = {Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination.},
  author = {Kameyama N and Ide A and Maeda H},
  year = {2026},
  journal = {Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences},
  doi = {10.1007/s40199-026-00661-7},
  url = {https://doi.org/10.1007/s40199-026-00661-7}
}

RIS

TY  - JOUR
TI  - Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination.
AU  - Kameyama N
AU  - Ide A
AU  - Maeda H
PY  - 2026
JO  - Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
DO  - 10.1007/s40199-026-00661-7
UR  - https://doi.org/10.1007/s40199-026-00661-7
ER  - 

APA

N, K., A, I., & H, M. (2026). Important potential risks not reflected in Japanese drug labeling: implications for risk management plan termination.. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. https://doi.org/10.1007/s40199-026-00661-7

Source records